Impact of c-MYC Protein Expression on Outcome of Patients with Early-Stage HER2+ Breast Cancer Treated with Adjuvant Trastuzumab NCCTG (Alliance) N9831

PURPOSE: This study investigated the association between tumor MYC protein expression and disease-free survival (DFS) of patients randomized to receive chemotherapy alone (Arm A) or chemotherapy with sequential (Arm B) or concurrent trastuzumab (Arm C) in the N9831 (Alliance) adjuvant HER2+ trastuzu...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Dueck, Amylou C., Reinholz, Monica M., Geiger, Xochiquetzal J., Tenner, Kathleen, Ballman, Karla, Jenkins, Robert B., Riehle, Darren, Chen, Beiyun, McCullough, Ann E., Davidson, Nancy E., Martino, Silvana, Sledge, George W., Kaufman, Peter A., Kutteh, Leila A., Gralow, Julie, Harris, Lyndsay N., Ingle, James N., Lingle, Wilma L., Perez, Edith A.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3805021/
https://ncbi.nlm.nih.gov/pubmed/23965903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-13-0558
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki